SCHEMBL20149751

SCHEMBL20149751

C=C(C)C(=O)OCCNC(=O)NCCOC(=O)NCCC[Si](OCC)(OCC)OCC

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.41
THRB P10828 1/20 0.40
TSHR P16473 2/20 0.39
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16985069 0.95 THRB (0.44) ACHETHRBTSHREPHX2
SCHEMBL631551 0.92 ACHE (0.49) ACHETHRBTSHR
SCHEMBL10752198 0.91 TSHR (0.45) ACHETHRBTSHR
SCHEMBL5925097 0.91 ACHE (0.45) ACHETHRBTSHR
SCHEMBL22493849 0.91 THRB (0.43) ACHETHRBTSHREPHX2
SCHEMBL12394959 0.89 THRB (0.51) ACHETHRBTSHR
SCHEMBL12394961 0.89 THRB (0.51) ACHETHRBTSHR
SCHEMBL21404644 0.89 TSHR (0.50) ACHETHRBTSHR
SCHEMBL17298779 0.87 THRB (0.38) ACHETHRBTSHR
SCHEMBL21404684 0.86 ACHE (0.50) ACHETHRBTSHREPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134912-A1 UREA (MULTI)-URETHANE (METH)ACRYLATE-SILANE COMPOSITIONS AND ARTICLES INCLUDING THE SAME 3M INNOVATIVE PROPERTIES CO (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134912-A1 UREA (MULTI)-URETHANE (METH)ACRYLATE-SILANE COMPOSITIONS AND ARTICLES INCLUDING THE SAME RCOR1, RUVBL1, RER1 ACHE 2780/4885THRB 2095/4885TSHR 1272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.